Bifogade filer
Kurs & Likviditet
Kalender
2024-11-12 | Kvartalsrapport 2024-Q3 |
2024-08-13 | Kvartalsrapport 2024-Q2 |
2024-05-15 | Ordinarie utdelning MOB 0.00 SEK |
2024-05-14 | Årsstämma 2024 |
2024-05-07 | Kvartalsrapport 2024-Q1 |
2024-02-13 | Bokslutskommuniké 2023 |
2023-11-07 | Kvartalsrapport 2023-Q3 |
2023-10-09 | Extra Bolagsstämma 2023 |
2023-08-03 | Kvartalsrapport 2023-Q2 |
2023-05-24 | Split MOB 10:1 |
2023-05-17 | Ordinarie utdelning MOB 0.00 SEK |
2023-05-16 | Årsstämma 2023 |
2023-05-09 | Kvartalsrapport 2023-Q1 |
2023-02-07 | Bokslutskommuniké 2022 |
2022-11-08 | Kvartalsrapport 2022-Q3 |
2022-08-09 | Kvartalsrapport 2022-Q2 |
2022-05-17 | Ordinarie utdelning MOB 0.00 SEK |
2022-05-16 | Årsstämma 2022 |
2022-05-10 | Kvartalsrapport 2022-Q1 |
2022-05-03 | Extra Bolagsstämma 2022 |
2022-02-08 | Bokslutskommuniké 2021 |
2021-11-09 | Kvartalsrapport 2021-Q3 |
2021-08-10 | Kvartalsrapport 2021-Q2 |
2021-05-11 | Kvartalsrapport 2021-Q1 |
2021-03-31 | Ordinarie utdelning MOB 0.00 SEK |
2021-03-30 | Årsstämma 2021 |
2021-02-09 | Bokslutskommuniké 2020 |
2020-12-01 | Extra Bolagsstämma 2020 |
2020-05-12 | Kvartalsrapport 2020-Q3 |
2020-02-11 | Kvartalsrapport 2020-Q2 |
2019-11-19 | Kvartalsrapport 2020-Q1 |
2019-11-04 | Inlösen MOB 46.5 |
2019-10-31 | Ordinarie utdelning MOB 0.00 SEK |
2019-10-30 | Årsstämma 2020 |
2019-08-29 | Bokslutskommuniké 2019 |
2019-05-16 | Ordinarie utdelning MOB 0.00 SEK |
2019-05-15 | Årsstämma 2019 |
2019-05-14 | Kvartalsrapport 2019-Q1 |
2019-03-15 | Extra Bolagsstämma 2019 |
2019-02-12 | Bokslutskommuniké 2018 |
2018-11-06 | Kvartalsrapport 2018-Q3 |
2018-08-07 | Kvartalsrapport 2018-Q2 |
2018-05-16 | Ordinarie utdelning MOB 0.00 SEK |
2018-05-15 | Årsstämma 2018 |
2018-05-08 | Kvartalsrapport 2018-Q1 |
2018-02-13 | Bokslutskommuniké 2017 |
2017-11-13 | Kvartalsrapport 2017-Q3 |
2017-08-08 | Kvartalsrapport 2017-Q2 |
2017-05-17 | Ordinarie utdelning MOB 0.00 SEK |
2017-05-16 | Årsstämma 2017 |
2017-05-09 | Kvartalsrapport 2017-Q1 |
2017-02-14 | Bokslutskommuniké 2016 |
2016-11-08 | Kvartalsrapport 2016-Q3 |
2016-08-09 | Kvartalsrapport 2016-Q2 |
2016-05-19 | Ordinarie utdelning MOB 0.00 SEK |
2016-05-18 | Årsstämma 2016 |
2016-05-10 | Kvartalsrapport 2016-Q1 |
2016-02-17 | Bokslutskommuniké 2015 |
2015-11-10 | Kvartalsrapport 2015-Q3 |
2015-08-11 | Kvartalsrapport 2015-Q2 |
2015-05-12 | Ordinarie utdelning MOB 0.00 SEK |
2015-05-11 | Årsstämma 2015 |
2015-05-11 | Bokslutskommuniké 2014 |
2015-05-11 | Kvartalsrapport 2015-Q1 |
2015-02-27 | Bokslutskommuniké 2014 |
2014-11-14 | Kvartalsrapport 2014-Q3 |
2014-08-13 | Kvartalsrapport 2014-Q2 |
2014-05-14 | Ordinarie utdelning MOB 0.00 SEK |
2014-05-13 | Årsstämma 2014 |
2014-05-13 | Kvartalsrapport 2014-Q1 |
2014-02-20 | Bokslutskommuniké 2013 |
2013-11-05 | Kvartalsrapport 2013-Q3 |
2013-08-06 | Kvartalsrapport 2013-Q2 |
2013-05-21 | Kvartalsrapport 2013-Q1 |
2013-05-21 | Analytiker möte 2013 |
2013-04-24 | Ordinarie utdelning MOB 0.00 SEK |
2013-04-23 | Årsstämma 2013 |
2013-03-13 | 15-7 2013 |
2013-02-05 | Bokslutskommuniké 2012 |
2012-11-19 | Extra Bolagsstämma 2012 |
2012-10-25 | Kvartalsrapport 2012-Q3 |
2012-09-20 | Kapitalmarknadsdag 2012 |
2012-08-28 | Kvartalsrapport 2012-Q2 |
2012-06-11 | 15-7 2012 |
2012-04-24 | Ordinarie utdelning MOB 0.00 SEK |
2012-04-23 | Årsstämma 2012 |
2012-04-23 | Kvartalsrapport 2012-Q1 |
2012-02-09 | Bokslutskommuniké 2011 |
2011-11-29 | 15-7 2011 |
2011-10-28 | Kvartalsrapport 2011-Q3 |
2011-08-12 | Kvartalsrapport 2011-Q2 |
2011-04-18 | Kvartalsrapport 2011-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
STOCKHOLM, November 3[rd], 2022 - In accordance with the resolution of the Annual General Meeting on May 16[th], 2022, the Chairman of the Board has contacted the company's three largest shareholders or group of shareholders in terms of votes to form a Nomination Committee. These shareholders have been invited to appoint one representative each who, together with the Chairman of the Board, will comprise the Nomination Committee. As not all of the company's three largest shareholders or group of shareholders have wished to appoint such representative, the fourth largest shareholder/group of shareholders have been invited to appoint one representative and so on until the Nomination Committee now comprises of four members, in accordance with the resolution of the Annual General Meeting on May 16[th], 2022.
- Gillis Cullin, appointed by Östersjöstiftelsen
- Fredrik Åsberg
- Martin Öhrn, appointed by Anders Lundmark
- Kerstin Valinder Strinnholm, Chairman of the Board
Together, the Nomination Committee represents 12.6 percent of the shares in Moberg Pharma as of September 30[th], 2022.
The Nomination Committee shall submit proposals for the fiscal year January - December 2022 by the Annual General Meeting pertaining to the election of Chairman of the Board, fees and composition of the Board, auditors' fees and the election of auditors.
The Annual General Meeting for the fiscal year January - December 2022 will be held on May 16[th] 2023.
Shareholders wishing to submit proposals to Moberg Pharma's Nomination Committee can do so by e-mail to info@mobergpharma.seby March 28[th], 2023.
About this information
The information was submitted for publication, through the agency of the contact person set out below, at 8.30 a.m. CET on November 3[rd], 2022.
Anna Ljung, CEO, Phone: +46 8 522 307 01, e-mail: anna.ljung@mobergpharma.se